Search

Background: From 2013 the World Medical Association's Declaration of Helsinki explicitly requires pre-registration of a study involving human subjects. The registration gives a chance for improvement of design and avoidance of bias., Objective: The aim of this article was to describe process of bearing decision to create regional registry of clinical studies for Balkan countries., Methods: After finding relevant studies about research registries and designing the concept and structure of future regional registry an article was published in IJBH journal. The article was than used as basis for discussion at 2020 meeting of Academy of Medical Sciences of Bosnia and Herzegovina (AMSBH), and final decision was made by the Academy to create the research registry., Results: Regional registry of clinical studies will be under the auspices of AMSBH and web-based, with the option of online registration of new studies. The data required to be entered in the moment of registration relate to key elements of research plan: topic, variables, sample, type of the study and the study population. After applying for registration of a clinical study, the authors will soon receive the review made by the AMSBH expert committee. The application could be accepted, rejected or returned for major or minor revision. After an application is accepted, it will be deposited in the searchable database and given the registration number., Conclusion: The AMSBH's decision to create the regional registry of clinical studies will satisfy needs of researchers from Balkan countries in the first place, who share cultural and lingual similarities. It will also help with increasing standards of clinical research in the region., Competing Interests: None declared, (© 2020 Izet Masic, Slobodan M. Jankovic, Asim Kurjak, Doncho M. Donev, Muharem Zildzic, Osman Sinanovic, Izet Hozo, Snjezana Milicevic, Sefik Hasukic, Emir Mujanovic, Kenan Arnautovic, Senaid Trnacevic, Enisa Mesic, Mirza Biscevic, Mustafa Sefic, Vjekoslav Gerc, Abdulah Kucukalic, Zlatko Hrgovic, Jacob Bergsland, Mirko Grujic.)

Background: Enormous number of medical journals published around the globe requires standardization of editing practice., Objective: The aim of this article was to enlist main principles of editing biomedical scientific journals adopted at annual meeting of Academy of Medical Sciences of Bosnia & Herzegovina (AMSB&H)., Methods: The evidence for writing this Guideline was systematically searched for during September 2020 in the PUBMED and GOOGLE SCHOLAR databases. The inclusion criteria were: original studies, systematic reviews, invited expert opinions, guidelines and editorials. The exclusion criteria were narrative reviews and uninvited opinion articles. The retrieved evidence was analyzed by members of the AMSB&H, then discussed at 2020 annual meeting of the AMSB&H and adopted by nominal group technique., Results: In total 14 recommendations were made, based on A to C class of evidence. The editors should educate potential authors and instruct them how to structure their manuscript, how to write every segment of the manuscript, and take care about correct use of statistical tests. Plagiarism detection softwares should be used regularly, and statistical and technical editing should be rigorous and thorough. International standards of reporting specific types of studies should be followed, and principles of ethical and responsible behavior of editors, reviewers and authors should be published on the journal's web site. The editors should insist on registration of clinical studies before submission, and check whether non-essential personal information is removed from the articles; when essential personal information has to be included, an article should not be published without signed informed consent by the patient to whom these information relate., Conclusions: Principles of editing biomedical scientific journals recommended in this guideline should serve as one of the means of improving medical journals' quality., Competing Interests: None declared., (© 2020 Izet Masic, Slobodan M. Jankovic, Asim Kurjak, Doncho M. Donev, Muharem Zildzic, Osman Sinanovic, Izet Hozo, Snjezana Milicevic, Sefik Hasukic, Emir Mujanovic, Kenan Arnautovic, Senaid Trnacevic, Enisa Mesic, Mirza Biscevic, Mustafa Sefic, Vjekoslav Gerc, Abdulah Kucukalic, Zlatko Hrgovic, Jacob Bergsland, Mirko Grujic.)

Background: One of the most vulnerable group to cope with the consequences of COVID-19 pandemic are women, particularly pregnant ones., Objective: The aim of this article was to make review of the scientific literature to show clearly that pandemic is not so dangerous neither for mother nor her unborn and newborn children., Results and Discussion: It should be stated that most of the scientific papers on COVID-19 are currently being conducted in a way that would probably be completely unacceptable to serious science in any other circumstances. Taking into account everything we have learned about the SARS-CoV-2 virus so far it comes as a surprise that there has not been a more intense scientific debate on whether the blind lockdown model, implemented by most national governments, was truly an appropriate response to the challenges posed by the pandemic., Conclusion: Deep analysis what science in perinatal medicine did assess and what it recommended to perinatal world it may be followed by principles that the research of the members of the Academy will not be the first to be published, but we certainly aim that the scientific evidence published by Academy is fast, reliable and implementable., Competing Interests: None declared., (© 2020 Asim Kurjak1, Olus Api2, Izet Masic3.)